HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cardiopulmonary Bypass (Heart-Lung Bypass)

Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs.
Also Known As:
Heart-Lung Bypass; Bypass, Cardiopulmonary; Bypass, Heart-Lung; Bypasses, Cardiopulmonary; Bypasses, Heart-Lung; Cardiopulmonary Bypasses; Heart Lung Bypass; Heart-Lung Bypasses
Networked: 12373 relevant articles (360 outcomes, 903 trials/studies)

Relationship Network

Therapy Context: Research Results

Experts

1. Grocott, Hilary P: 28 articles (03/2017 - 02/2002)
2. Hetzer, Roland: 28 articles (12/2016 - 08/2002)
3. Bellomo, Rinaldo: 26 articles (01/2022 - 10/2002)
4. Ranucci, Marco: 22 articles (11/2019 - 10/2004)
5. Angelini, Gianni D: 21 articles (03/2022 - 10/2002)
6. Gaynor, J William: 21 articles (01/2021 - 01/2003)
7. Newman, Mark F: 21 articles (11/2016 - 02/2002)
8. Levy, Jerrold H: 20 articles (01/2022 - 05/2004)
9. Borger, Michael A: 19 articles (01/2022 - 03/2002)
10. Mathew, Joseph P: 19 articles (01/2019 - 01/2003)

Related Diseases

1. Hypothermia
2. Hemorrhage
01/01/2015 - "Intra-operative cell salvage (CS) was reported to be ineffective, safe and not cost-effective in low-bleeding-risk cardiac surgery with cardiopulmonary bypass (CPB), but studies in high-bleeding-risk cardiac surgery are limited. "
05/18/2023 - "The application of autologous platelet-rich plasma in a long-time cardiopulmonary bypass aortic root reconstruction can reduce the amount of allogeneic blood transfusion and the occurrence of bleeding events, which is beneficial for blood protection."
12/01/2020 - "We performed a single-center, phase 1b/2a, randomized controlled trial on infants 2.5 to 12 kg undergoing cardiopulmonary bypass surgery, aimed at (1) demonstrating the feasibility of an intraoperative point-of-care test, rotational thromboelastometry, to screen out patients at low risk of postoperative bleeding and then guide individualized FC dosing in high-risk patients and (2) determining the dose, safety, and efficacy of intraoperative FC supplementation. "
04/01/2019 - "In the univariate model, to predict the patients who might stay at the hospital for more than 1 week and who might stay at the ICU for more than 3 days, we considered the significant efficacy of postoperative blood transfusion, bleeding amount, and the cardiopulmonary bypass time (p < 0.05). "
12/01/2001 - "Although extracorporeal circulation can modify platelet numbers and function, our ongoing data could show significant reduction in the loss of platelets induced by cardiopulmonary bypass, minor postoperative bleeding, and a minor transfusion requirement in general."
3. Heart Arrest (Cardiac Arrest)
4. Congenital Heart Defects (Congenital Heart Defect)
5. Ischemia

Related Drugs and Biologics

1. Heparin (Liquaemin)
2. Aprotinin (Trasylol)
3. Nitric Oxide (Nitrogen Monoxide)
4. Cardioplegic Solutions
5. Vasopressins (Vasopressin)
6. Simendan (Levosimendan)
7. Anticoagulants
8. Crystalloid Solutions
9. Oxygen (Dioxygen)
10. Solutions

Related Therapies and Procedures

1. Coronary Artery Bypass (Coronary Artery Bypass Surgery)
2. Therapeutics
3. Sternotomy
4. Induced Heart Arrest (Cardioplegia)
5. Resuscitation